Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2005 May;5(2):38-42.
doi: 10.17305/bjbms.2005.3282.

Modern approach in treatment of diabetes insipidus

Affiliations
Review

Modern approach in treatment of diabetes insipidus

Elvedina Kapić et al. Bosn J Basic Med Sci. 2005 May.

Abstract

In this paper we have reviewed the position of desmopressin in the treatment of diabetes insipidus. Desmopressin is a synthetic analog of vasopressin, with more pronounced antidiuretic effect. It is treatment of choice in substitution therapy of diabetes insipidus. Its application before sleeping time can reduce nocturnal enuresis, so it has a place in the treatment of enuresis nocturna. Antidiuretic effect of desmopressin is the result of agonistic effect on V2 receptors in the renal tubules. The efficacy and safety of desmopressin in mentioned indications was confirmed in clinical studies.

PubMed Disclaimer

Similar articles

Cited by

References

    1. MICROMEDEX*(2005) Copyright Micromedex Inc. 1974/2005. Micromedex*Healthcare Series 2005;123.3. Drugdex Drug Evaluation:LYPRESSIN
    1. Lethagen S, Flordal P, Van Aken H, et al. The UK guidelines for the use of desmopressin in patients with von Willebrand's disease. Eur J Anaesthesiol. 1997;14(14):19–22. - PubMed
    1. PDR. Physicians'Desk Reference, 57 Edition, 2003, Copyright 2003 and published by Thomson PDR at Montvale, NJ, 732734. 2003
    1. Hunsballe J.M, Hansen T.K, Rittig S, et al. The efficacy of DDAVP is related to the circadian rhythm of urine output in patients with persisting nocturnal enuresis. Clin Endocrinol (Oxf) 1998;49(6):793–801. - PubMed
    1. Takahashi-Tezuka M, Kobayashi J, Otabe M, et al. A clinical feature of hyperlipidemia in patients with central diabetes insipidus. Endocr J. 2000;47:557–562. - PubMed